Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)

Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)

Background: Lassa Fever (LF), is a severe viral disease prevalent in Western Africa. It is classified as a priority disease by the World Health Organization (WHO). Ribavirin is the recommended therapy despite weak evidence of its efficacy. Promising therapeutic agents are becoming available for eval...

Full description

Bibliographic Details
Main Authors: Duvignaud, A, Jaspard, M, Etafo, IC, Serra, B, Abejegah, C, Gabillard, D, Doutchi, M, Alabi, JF, Adedokun, MA, Akinpelu, AO, Oyegunle, OO, Etafo, J, Dede, AO, Onyechi, MN, Ireneh, MU, Gbenga-Ayeni, O, Fadiminiyi, KG, Ehigbor, PI, Ouattara, E, Levy-Marchal, C, Karcher, S, N'guessan-Koffi, L, Ahyi, I, Amani, E, Diabaté, M, Siloué, B, Schaeffer, J, Augier, A, Ogbaini-Emovon, E, Salam, AP, Horby, P, Ahmed, LA, Günther, S, Adedosu, AN, Anglaret, X, Ayodeji, OO, Malvy, D
Format: Journal article
Language:English
Published: Elsevier 2020

Similar Items

Similar Items